GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: IFN-alpha-2 | interferon alpha-2 | Roferon A®
IFN-α2 is an approved drug (FDA (1989))
Compound class:
Endogenous peptide in human, mouse or rat
Comment: IFN-α2 is a type I IFN. The sequence of the recombinant peptide used clinically and known as interferon alfa-2a, is identical to that of human IFN-α2. Interferon α-2a has anti-viral, immunomodulatory and antineoplastic actions.
Pegylated IFN-α-2a is on the World Health Organization's List of Essential Medicines.
Species: Human
|
For advanced searching click here to open chemical structure editor
Other Similar Sequences  |
|
| IFN-α1/13 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α10 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α14 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α16 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α17 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α21 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α4 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α5 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α6 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α7 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α8 {Sp: Human} |
TargetsInterferon-α/β receptor |
| peginterferon alfa-2b |
TargetsInterferon-α/β receptor; interferon α/β receptor 1 |
| IFN-α2b (recombinant human) | |
